1 / 19

Lymphadenopathy

References. Ferrer R. Lymphadenopathy: Differential Diagnosis and Evaluation. American Family Physician October 15, 1998Nelson Textbook of Pediatrics. 17th edition. 2004Oski's Pediatrics, Principles

kerryn
Download Presentation

Lymphadenopathy

An Image/Link below is provided (as is) to download presentation Download Policy: Content on the Website is provided to you AS IS for your information and personal use and may not be sold / licensed / shared on other websites without getting consent from its author. Content is provided to you AS IS for your information and personal use only. Download presentation by click this link. While downloading, if for some reason you are not able to download a presentation, the publisher may have deleted the file from their server. During download, if you can't get a presentation, the file might be deleted by the publisher.

E N D

Presentation Transcript


    1. Lymphadenopathy Surapon Wiangnon

    2. References Ferrer R. Lymphadenopathy: Differential Diagnosis and Evaluation. American Family Physician October 15, 1998 Nelson Textbook of Pediatrics. 17th edition. 2004 Oski’s Pediatrics, Principles & Practice. 2006

    3. General principles usually a result of benign infectious causes. Mostly diagnosed on the basis of a careful history and physical examination. Localized adenopathy should prompt a search for an adjacent precipitating lesion. In general, cervical, axillary lymph nodes greater than 1 cm and inguinal > 1.5 cm in diameter are considered to be abnormal. Generalized adenopathy should always prompt further clinical investigation.

    4. Definition Lymphadenopathy refers to nodes that are abnormal in either size, consistency or number. "generalized" if lymph nodes are enlarged in two or more noncontiguous areas "localized" if only one area is involved. Generalized lymphadenopathy almost always indicates the presence of a significant systemic disease.

    6. Epidemiology Population-based study (Dutch): 10% of patients with unexplained adenopathy required referral to a subspecialist, and only 1 percent had a malignancy In primary care settings, patients 40 years of age and older with unexplained lymphadenopathy have about a 4 % risk of cancer versus a 0.4% risk in patients younger than age 40. (Fijten GH, Blijham GH. Unexplained lymphadenopathy in family practice. An evaluation of the probability of malignant causes and the effectiveness of physicians' workup. J Fam Pract 1988;27: 373-6)

    7. Evaluation of possible adenopathy Is the swelling a lymph node? Is the node enlarged? What are the characteristics of the node? Is the adenopathy local or genralized?

    8. Physical examination Five characteristics should be noted and described: Size. normal if < 1 cm in diameter; Abnormal: epitrochlear nodes > 0.5 cm inguinal nodes > 1.5 cm Pain/Tenderness. inflammatory process or suppuration, hemorrhage into the necrotic center of a malignant node. Consistency. Stony-hard nodes: cancer, usually metastatic. Very firm, rubbery nodes: lymphoma. Softer nodes: infections or inflammatory conditions. Suppurant nodes may be fluctuant. "shotty" (small nodes that feel like buckshot under the skin) cervical nodes of children with viral illnesses. Matting. benign (e.g., tuberculosis, sarcoidosis or lymphogranuloma venereum) malignant (e.g., metastatic carcinoma or lymphomas). Location.

    9. Lymph Node Groups: Location, Lymphatic Drainage and Selected Differential Diagnosis

    10. Lymph Node Groups: Location, Lymphatic Drainage and Selected Differential Diagnosis

    11. Lymph Node Groups: Location, Lymphatic Drainage and Selected Differential Diagnosis

    12. Common causes of generalized lymphadenopathy Infections: Typhoid fever, TB, AIDS, mononucleosis, CMV, rubella, varicella, rubeola, histoplasmosis, toxoplasmosis Autoimmune diseases: RA, SLE, dermatomyositis Malignancies: primary: HD, NHL, histiocytic disorders, metastatic: leukemia, NB, RMS Lipid storage diseases: Gaucher, Niemann-Pick Drug reactions

    13. Medications That May Cause Lymphadenopathy Allopurinol Atenolol Captopril Carbamazepine Cephalosporins Gold Hydralazine . Penicillin Phenytoin Primidone Pyrimethamine Quinidine Sulfonamides Sulindac

    14. Common causes of regional node enlargement Occipital: roseola, rubella, scalp infections Preauricular: cat-scrath disease, eye infections cervical: Streptococcal/staphyllococcal adenitis or tonsillitis, mononucleosis, toxoplasmosis, maligancies, Kawasaki disease Submaxillary: HD, NHL, tuberculosis, histoplasmosis

    15. Common causes of regional node enlargement Axillary: infections of arm/chest wall, cat-scratch disease, malignancies Mediastinal: maligancies (T-cell leukemia/lymphoma, thymoma, teratoma), TB Abdominal: malignancies, mesenteric adenitis Illioinguinal: infections of leg, groin

    16. Indication for biopsy increase in size over baseline in 2 weeks no decease in size in 4-6 weeks no regression to normal in 8-12 weeks development of new signs and symptoms

    17. Caution! Biopsy should be avoided in patients with probable viral illness because lymph node pathology in these patients may sometimes simulate lymphoma and lead to a false-positive diagnosis of malignancy. Fine-needle aspiration is occasionally considered an alternative to excisional biopsy but is often unhelpful.

    18. Final Comment In most patients, lymphadenopathy has a readily diagnosable infectious cause. A diagnosis of less obvious causes can often be made after considering the patient's age, the duration of the lymphadenopathy and whether localizing signs or symptoms, constitutional signs or epidemiologic clues are present. When the cause of the lymphadenopathy remains unexplained, a 10-14 day (3-4-week) observation period is appropriate when the clinical setting indicates a high probability of benign disease.

More Related